Yaz / Yasmin Drug Side Effects Class Action

Yaz / Yasmin Drug Side Effects Class Action

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');

lang: en_US

Share

Active

Join This Class Action

.documentsbtn span.plus,

.documentsbtn span.minus{

display:none;

}

.documentsbtn[aria-expanded="false"] span.plus,

.documentsbtn[aria-expanded="true"] span.minus{

display:block;

float: left;

margin: 0 10px 0px 0;

}

+ - Documents (1)

QC Nov 22, 2009 [en]

Motion for Authorization

CONSUMER LAW GROUP has launched a Canada-wide class action lawsuit against the makers of the drug Yaz and Yasmin (drospirenone and ethinyl estradiol), manufactured by Bayer and Berlex, on behalf of individuals who have suffered from a condition known as hyperkalemia (an increase in potassium level in the blood), or problems related to the drugs’ diuretic qualities, or problems related to the drugs’ hormonal misbalance.

Hyperkalemia, diuretic issues, and hormonal imbalances can lead to the following health problems:

• Deep vein thrombosis

• Blood clots

• Pulmonary embolism

• Heart attacks

• Stroke

• Gallbladder problems and infections

• Liver failure

• Kidney failure

• Severe anxiety

• Depression

• Sudden death

To post a comment, please visit our blogs at www.yazclassaction.blogspot.com and www.yasminclassaction.blogspot.com

The class action lawsuit identifies the group of affected persons as:

o All persons residing in Canada who have taken and/or purchased the drugs YAZ and/or YASMIN (drospirenone and ethinyl estradiol) since January 12th 2005 and their successors, assigns, family members, and dependants or any other group to be determined by th